Filters
How to Win the 'War on Regulation'

Because of as-reported accounting, too many investors missed out on incredible gains...

Securities Analyzed
  • META
AI Hasn't Transformed This Nuclear-Energy Giant

With so many tailwinds for this business, investors are likely tempted to buy in...

Securities Analyzed
  • CEG
From Ugly and Uncool to 870% Upside

What started as a quirky, polarizing shoe soon had serious buzz – and serious buyers...

Securities Analyzed
  • CROX
A $5.5 Trillion Misunderstanding

It's natural to worry that taking trillions of dollars in future revenue away will only make things worse...

U.S. Consumers Are Footing the Pharma Bill

The U.S. needs to take a closer look at pharma and biotech companies...

Big Pharma's Big Conundrum

U.S. consumers need a break at the pharmacy counter...

This Industry Laggard Is Locked in the AI Game

Over the past few years, this business has been quietly trying to put its laggard reputation behind it...

Securities Analyzed
  • HPE
Two Reasons to Expect a Stronger Economy in 2025

This is when companies' fortunes can start changing for the better...

AI Isn't Replacing You... Someone Using It Will

Because of how fast it’s happening, not all companies are building their AI tools the right way...

Even the Old Dogs Are Jumping Into AI

This business has been nothing short of explosive...

Securities Analyzed
  • DELL
  • GOOGL
  • MSFT
  • NVDA